<?xml version='1.0' encoding='utf-8'?>
<document id="20664903"><sentence text="A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial."><entity charOffset="44-55" id="DDI-PubMed.20664903.s1.e0" text="Fluvastatin" /><entity charOffset="60-72" id="DDI-PubMed.20664903.s1.e1" text="Atorvastatin" /><pair ddi="false" e1="DDI-PubMed.20664903.s1.e0" e2="DDI-PubMed.20664903.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s1.e0" e2="DDI-PubMed.20664903.s1.e1" /></sentence><sentence text="Drug-drug interaction between statins metabolised by cytochrome P450 3A4 and clopidogrel have been claimed to attenuate the inhibitory effect of clopidogrel"><entity charOffset="77-88" id="DDI-PubMed.20664903.s2.e0" text="clopidogrel" /><entity charOffset="145-156" id="DDI-PubMed.20664903.s2.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.20664903.s2.e0" e2="DDI-PubMed.20664903.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s2.e0" e2="DDI-PubMed.20664903.s2.e1" /></sentence><sentence text=" However, published data regarding this drug-drug interaction are controversial" /><sentence text=" We aimed to determine the effect of fluvastatin and atorvastatin on the inhibitory effect of dual antiplatelet therapy with acetylsalicylic acid (ASA) and clopidogrel"><entity charOffset="37-48" id="DDI-PubMed.20664903.s4.e0" text="fluvastatin" /><entity charOffset="53-65" id="DDI-PubMed.20664903.s4.e1" text="atorvastatin" /><entity charOffset="125-145" id="DDI-PubMed.20664903.s4.e2" text="acetylsalicylic acid" /><entity charOffset="147-150" id="DDI-PubMed.20664903.s4.e3" text="ASA" /><entity charOffset="156-167" id="DDI-PubMed.20664903.s4.e4" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e0" e2="DDI-PubMed.20664903.s4.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e0" e2="DDI-PubMed.20664903.s4.e1" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e0" e2="DDI-PubMed.20664903.s4.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e0" e2="DDI-PubMed.20664903.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e0" e2="DDI-PubMed.20664903.s4.e4" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e1" e2="DDI-PubMed.20664903.s4.e1" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e1" e2="DDI-PubMed.20664903.s4.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e1" e2="DDI-PubMed.20664903.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e1" e2="DDI-PubMed.20664903.s4.e4" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e2" e2="DDI-PubMed.20664903.s4.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e2" e2="DDI-PubMed.20664903.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e2" e2="DDI-PubMed.20664903.s4.e4" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e3" e2="DDI-PubMed.20664903.s4.e3" /><pair ddi="false" e1="DDI-PubMed.20664903.s4.e3" e2="DDI-PubMed.20664903.s4.e4" /></sentence><sentence text=" One hundred one patients with symptomatic stable coronary artery disease undergoing percutaneous coronary intervention and drug-eluting stent implantation were enrolled in this prospective randomised study" /><sentence text=" After an interval of two weeks under dual antiplatelet therapy with ASA and clopidogrel, without any lipid-lowering drug, 87 patients were randomised to receive a treatment with either fluvastatin 80 mg daily or atorvastatin 40 mg daily in addition to the dual antiplatelet therapy for one month"><entity charOffset="77-88" id="DDI-PubMed.20664903.s6.e0" text="clopidogrel" /><entity charOffset="213-225" id="DDI-PubMed.20664903.s6.e1" text="atorvastatin" /><entity charOffset="69-80" id="DDI-PubMed.20664903.s6.e2" text="ASA" /><pair ddi="false" e1="DDI-PubMed.20664903.s6.e2" e2="DDI-PubMed.20664903.s6.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s6.e2" e2="DDI-PubMed.20664903.s6.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s6.e2" e2="DDI-PubMed.20664903.s6.e1" /><pair ddi="false" e1="DDI-PubMed.20664903.s6.e0" e2="DDI-PubMed.20664903.s6.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s6.e0" e2="DDI-PubMed.20664903.s6.e1" /></sentence><sentence text=" Platelet aggregation was assessed using light transmission aggregometry and whole blood impedance platelet aggregometry prior to randomisation and after one month of receiving assigned statin and dual antiplatelet treatment" /><sentence text=" Platelet function assessment after one month of statin and dual antiplatelet therapy did not show a significant change in platelet aggregation from 1st to 2nd assessment for either statin group" /><sentence text=" There was also no difference between atorvastatin and fluvastatin treatment arms"><entity charOffset="38-50" id="DDI-PubMed.20664903.s9.e0" text="atorvastatin" /><entity charOffset="55-66" id="DDI-PubMed.20664903.s9.e1" text="fluvastatin" /><pair ddi="false" e1="DDI-PubMed.20664903.s9.e0" e2="DDI-PubMed.20664903.s9.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s9.e0" e2="DDI-PubMed.20664903.s9.e1" /></sentence><sentence text=" In conclusion, neither atorvastatin 40 mg daily nor fluvastatin 80 mg daily administered in combination with standard dual antiplatelet therapy following coronary drug-eluting stent implantation significantly interfere with the antiaggregatory effect of ASA and clopidogrel"><entity charOffset="24-36" id="DDI-PubMed.20664903.s10.e0" text="atorvastatin" /><entity charOffset="53-67" id="DDI-PubMed.20664903.s10.e1" text="fluvastatin 80" /><entity charOffset="255-258" id="DDI-PubMed.20664903.s10.e2" text="ASA" /><entity charOffset="263-274" id="DDI-PubMed.20664903.s10.e3" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e0" e2="DDI-PubMed.20664903.s10.e0" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e0" e2="DDI-PubMed.20664903.s10.e1" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e0" e2="DDI-PubMed.20664903.s10.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e0" e2="DDI-PubMed.20664903.s10.e3" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e1" e2="DDI-PubMed.20664903.s10.e1" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e1" e2="DDI-PubMed.20664903.s10.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e1" e2="DDI-PubMed.20664903.s10.e3" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e2" e2="DDI-PubMed.20664903.s10.e2" /><pair ddi="false" e1="DDI-PubMed.20664903.s10.e2" e2="DDI-PubMed.20664903.s10.e3" /></sentence><sentence text="" /></document>